Article
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets
1 Nov 2024
Abstract excerpt
INTRODUCTION: Glioblastoma is the most aggressive brain tumor, typically associated with poor prognosis. Its treatment is challenging due to the peculiar glioblastoma cell biology and its microenvironment complexity. Specifically, a small fraction of glioma stem cells within the tumor mass drives tumor growth and invasiveness by hijacking brain resident and immune cells. This process also involves modification of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
